EFFICACY OF AZTREONAM IN PULMONARY EXACERBATIONS OF CYSTIC-FIBROSIS

被引：24

作者：

BOSSO, JA

BLACK, PG

MATSEN, JM

机构：

[1] UNIV UTAH,SCH MED,DEPT PEDIAT,SALT LAKE CITY,UT 84112

[2] UNIV UTAH,SCH MED,DEPT PATHOL,SALT LAKE CITY,UT 84112

来源：

关键词：

D O I：

10.1097/00006454-198704000-00010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：393 / 397

页数：5

共 22 条

[1] ALDER KB, 1983, JAMA, V249, P1615
[2] ARONOFF SC, 1984, ANTIMICROB AGENTS CH, V25, P279, DOI 10.1128/AAC.25.2.279
[3] BAUER AW, 1966, AM J CLIN PATHOL, V45, P493
[4] IS ANTI-PSEUDOMONAS THERAPY WARRANTED IN ACUTE RESPIRATORY EXACERBATIONS IN CHILDREN WITH CYSTIC-FIBROSIS
BEAUDRY, PH
MARKS, MI
MCDOUGALL, D
DESMOND, K
RANGEL, R
[J]. JOURNAL OF PEDIATRICS, 1980, 97 (01) : 144 - 147
[5] PENETRATION OF AZTREONAM INTO HUMAN BRONCHIAL-SECRETIONS
BECHARD, DL
HAWKINS, SS
DHRUV, R
FRIEDHOFF, LT
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1985, 27 (02) : 263 - 264
[6] SHOULD PULMONARY EXACERBATIONS IN CYSTIC-FIBROSIS BE TREATED WITH ANTIBIOTICS
BOSSO, JA
[J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (10): : 825 - 826
[7] GUAY DRP, 1985, CLIN PHARMACY, V4, P516
[8] NAD-DEPENDENT INHIBITION OF PROTEIN-SYNTHESIS BY PSEUDOMONAS-AERUGINOSA TOXIN
IGLEWSKI, BH
KABAT, D
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (06) : 2284 - 2288
[9] INVITRO ACTIVITY OF AZTHREONAM, A MONOBACTAM ANTIBIOTIC
JACOBUS, NV
FERREIRA, MC
BARZA, M
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 22 (05) : 832 - 838
[10] Lennette E.H., 1980, MANUAL CLIN MICROBIO, P195